RGENE Inc. was founded in 2014 at San Francisco by Dr.Yu Zheng. Currently RGENE Inc. is supported by NIH/NIGMS phase II SBIR grant (GM105132).

Using advanced protein engineering and data mining methods, RGENE Inc. develops enabling enzyme reagents for molecular biotechnology. Our practice expands a variety of fields, including Next-Generation Sequencing, Epigenetics, Metagenomics.

RGENE Inc.’s founder, Dr.Yu Zheng, obtained his Ph.D. degree at bioinformatics from Boston University in 2004. He then spent 10 years at New England Biolabs Inc., from post-doc fellow to senior group leader. In 2014 he left NEB to establish RGENE Inc.